Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Preventing Age-Related Weight Gain in the Workplace With Daily Weighing (Weigh2Go)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03717428
Recruitment Status : Completed
First Posted : October 24, 2018
Last Update Posted : January 28, 2020
Sponsor:
Information provided by (Responsible Party):
David Levitsky, Cornell University

Brief Summary:
To examine the effectiveness of daily weighing to prevent age-related weight gain.

Condition or disease Intervention/treatment Phase
Weight Gain Device: Daily Weighing Group Device: Control group Not Applicable

Detailed Description:
Cornell employee's were recruited for a two-year weight gain prevention study. Height and weights were taken in our metabolic center. They were randomized into two group. The experimental group was given an internet based scale and asked to weigh themselves every morning immediately after rising. The other group was asked to return at the end of the study when they height and weight will again be measured.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 280 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Intervention Model Description: Effect of self-weighing to prevent age-related weight gain
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Preventing Age-Related Weight Gain in the Workplace With Daily Weighing
Actual Study Start Date : October 1, 2016
Actual Primary Completion Date : June 30, 2019
Actual Study Completion Date : September 30, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Body Weight

Arm Intervention/treatment
Experimental: Daily Weighing Group
This group will be weighed and height measured in our metabolic unit at the beginning and end of the two year experimental period. In addition, the intervention in Daily Weighing Group is that they will be given an internet based scale and asked to weigh themselves immediately after rising from bed every morning for the duration of the two year experimental period.
Device: Daily Weighing Group
The Experimental group will weigh themselves everyday
Other Name: Daily weighing

Active Comparator: Control Group
The only intervention for the control group is that they will be weighed and height measured at the beginning and end of the experimental period in our metabolic unit.
Device: Control group
This group will be weighed and measured at the beginning and end of the study and will not be weighing themselves daily
Other Name: Not weighing daily




Primary Outcome Measures :
  1. Weight Change [ Time Frame: 2 year ]
    body weight



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy, non-diabetic

Exclusion Criteria:

  • History of eating disorders

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03717428


Sponsors and Collaborators
Cornell University
Investigators
Layout table for investigator information
Study Director: Patrick Stover Cornell University

Layout table for additonal information
Responsible Party: David Levitsky, Professor, Cornell University
ClinicalTrials.gov Identifier: NCT03717428    
Other Study ID Numbers: 1606006401
First Posted: October 24, 2018    Key Record Dates
Last Update Posted: January 28, 2020
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Body Weight
Weight Gain
Signs and Symptoms
Body Weight Changes